"Oropharyngeal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the OROPHARYNX.
| Descriptor ID |
D009959
|
| MeSH Number(s) |
C04.588.443.665.710.684 C07.550.745.671 C09.647.710.685 C09.775.549.685
|
| Concept/Terms |
Oropharyngeal Neoplasms- Oropharyngeal Neoplasms
- Neoplasm, Oropharyngeal
- Oropharyngeal Neoplasm
- Oropharynx Neoplasms
- Neoplasm, Oropharynx
- Neoplasms, Oropharynx
- Oropharynx Neoplasm
- Neoplasms, Oropharyngeal
Cancer of Oropharnyx- Cancer of Oropharnyx
- Oropharnyx Cancer
- Oropharnyx Cancers
- Oropharyngeal Cancer
- Cancer, Oropharyngeal
- Cancers, Oropharyngeal
- Oropharyngeal Cancers
- Oropharynx Cancer
- Cancer, Oropharynx
- Cancers, Oropharynx
- Oropharynx Cancers
- Cancer of the Oropharynx
|
Below are MeSH descriptors whose meaning is more general than "Oropharyngeal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Oropharyngeal Neoplasms".
This graph shows the total number of publications written about "Oropharyngeal Neoplasms" by people in this website by year, and whether "Oropharyngeal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 3 | 0 | 3 |
| 2016 | 2 | 2 | 4 |
| 2019 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Oropharyngeal Neoplasms" by people in Profiles.
-
Association of HPV status with survival after surgical salvage of oropharyngeal cancers. Am J Otolaryngol. 2022 Jul-Aug; 43(4):103491.
-
Heterogeneity in the clinical presentation, diagnosis, and treatment initiation of p16-positive oropharyngeal cancer. Am J Otolaryngol. 2019 Sep - Oct; 40(5):626-630.
-
The association of medication use with clearance or persistence of oral HPV infection. Cancer Causes Control. 2016 Dec; 27(12):1491-1498.
-
National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinoma. Cancer. 2017 01 01; 123(2):273-282.
-
Human Papillomavirus (HPV) 16 E6 seropositivity is elevated in subjects with oral HPV16 infection. Cancer Epidemiol. 2016 08; 43:30-4.
-
Comparative effectiveness of induction chemotherapy for oropharyngeal squamous cell carcinoma: A population-based analysis. Oral Oncol. 2016 Mar; 54:58-67.
-
Cost-Effectiveness Analysis of Chemoradiation Therapy Versus Transoral Robotic Surgery for Human Papillomavirus-Associated, Clinical N2 Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys. 2016 Mar 01; 94(3):512-22.
-
Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy. JAMA Otolaryngol Head Neck Surg. 2015 May 01; 141(5):457-62.
-
A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infection. Sex Transm Dis. 2015 Feb; 42(2):93-7.
-
Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults. Am J Epidemiol. 2015 Jan 01; 181(1):40-53.